Sanda MG - Search Results

1

Concordance rates for benign prostatic disease among twins suggest hereditary influence.

Partin AW, Page WF, Lee BR, Sanda MG, Miller RN, Walsh PC. Partin AW, et al. Among authors: sanda mg. Urology. 1994 Nov;44(5):646-50. doi: 10.1016/s0090-4295(94)80197-5. Urology. 1994. PMID: 7526523 Free article.

2

Genetic susceptibility of benign prostatic hyperplasia.

Sanda MG, Beaty TH, Stutzman RE, Childs B, Walsh PC. Sanda MG, et al. J Urol. 1994 Jul;152(1):115-9. doi: 10.1016/s0022-5347(17)32831-8. J Urol. 1994. PMID: 7515446 Free article.

3

Gene therapy for urologic cancer.

Sanda MG, Simons JW. Sanda MG, et al. Urology. 1994 Oct;44(4):617-24. doi: 10.1016/s0090-4295(94)80075-8. Urology. 1994. PMID: 7524239 Review. No abstract available.

4

Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy.

Partin AW, Piantadosi S, Sanda MG, Epstein JI, Marshall FF, Mohler JL, Brendler CB, Walsh PC, Simons JW. Partin AW, et al. Among authors: sanda mg. Urology. 1995 May;45(5):831-8. doi: 10.1016/S0090-4295(99)80091-0. Urology. 1995. PMID: 7538245

5

Demonstration of a rational strategy for human prostate cancer gene therapy.

Sanda MG, Ayyagari SR, Jaffee EM, Epstein JI, Clift SL, Cohen LK, Dranoff G, Pardoll DM, Mulligan RC, Simons JW. Sanda MG, et al. J Urol. 1994 Mar;151(3):622-8. doi: 10.1016/s0022-5347(17)35032-2. J Urol. 1994. PMID: 8308972 Free article.

6

Histopathologic characterization of hereditary benign prostatic hyperplasia.

Doehring CB, Sanda MG, Partin AW, Sauvageot J, Juo H, Beaty TH, Epstein JI, Hill G, Walsh PC. Doehring CB, et al. Among authors: sanda mg. Urology. 1996 Oct;48(4):650-3. doi: 10.1016/S0090-4295(96)00329-9. Urology. 1996. PMID: 8886078 Free article.

7

Clinical and biological characteristics of familial benign prostatic hyperplasia.

Sanda MG, Doehring CB, Binkowitz B, Beaty TH, Partin AW, Hale E, Stoner E, Walsh PC. Sanda MG, et al. J Urol. 1997 Mar;157(3):876-9. J Urol. 1997. PMID: 9072590

8

Longitudinal cohort analysis of lethal prostate cancer progression in transgenic mice.

Hsu CX, Ross BD, Chrisp CE, Derrow SZ, Charles LG, Pienta KJ, Greenberg NM, Zeng Z, Sanda MG. Hsu CX, et al. Among authors: sanda mg. J Urol. 1998 Oct;160(4):1500-5. J Urol. 1998. PMID: 9751403

9

Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer.

Simons JW, Mikhak B, Chang JF, DeMarzo AM, Carducci MA, Lim M, Weber CE, Baccala AA, Goemann MA, Clift SM, Ando DG, Levitsky HI, Cohen LK, Sanda MG, Mulligan RC, Partin AW, Carter HB, Piantadosi S, Marshall FF, Nelson WG. Simons JW, et al. Among authors: sanda mg. Cancer Res. 1999 Oct 15;59(20):5160-8. Cancer Res. 1999. PMID: 10537292 Clinical Trial.

10

Early castration reduces prostatic carcinogenesis in transgenic mice.

Eng MH, Charles LG, Ross BD, Chrisp CE, Pienta KJ, Greenberg NM, Hsu CX, Sanda MG. Eng MH, et al. Among authors: sanda mg. Urology. 1999 Dec;54(6):1112-9. doi: 10.1016/s0090-4295(99)00297-6. Urology. 1999. PMID: 10604719

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

219 results

Search Page

Filters